How Media Coverage of Oral Minoxidil for Hair Loss Has Impacted Prescribing Habits
June 2024
in “
Cutis
”
New to Minoxidil? There is a guide in the encyclopedia. Read the guide → 
Studysummary Media coverage led to more dermatologists prescribing low-dose oral minoxidil for hair loss.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The publication of a New York Times article in August 2022 significantly influenced the prescribing habits of dermatologists regarding low-dose oral minoxidil (LDOM) for hair loss. A survey of 65 US-based board-certified dermatologists revealed that 42% began prescribing or increased their use of LDOM following the article. Data from Epiphany Dermatology and Summit Pharmacy showed substantial increases in LDOM prescriptions post-publication, with Epiphany Dermatology reporting 1,377 prescriptions in the 8 months following the article. Studies have shown LDOM to be a safe and effective treatment for alopecia, with minimal adverse effects. This highlights the powerful impact media coverage can have on medical practices and patient inquiries.
